AGI-14100
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
599.96
Molecular Formula
C29H22ClF4N5O3
Notes
Research use only, not for human use.
Receptor
Dehydrogenase
CAS Number
1448346-43-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal HLA DQ/DQ3 Antibody (HL-37) [PE]](https://cdn.genprice.uk/genprice/genprice5.png)
